Journal
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 86, Issue 2, Pages 127-134Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2014-307719
Keywords
-
Categories
Funding
- NCATS NIH HHS [UL1 TR001108] Funding Source: Medline
- NIA NIH HHS [R01 AG019771, P30 AG010133] Funding Source: Medline
Ask authors/readers for more resources
Objective We aimed to examine the association of apolipoprotein E (APOE) epsilon 4 genotype with neuroimaging markers of Alzheimer's disease: hippocampal volume, brain amyloid deposition and cerebral metabolism. Methods We performed a systematic review and meta-analysis of 14 cross-sectional studies identified in Pubmed from 1996 to 2014 (n=1628). The pooled standard mean difference (SMD) was used to estimate the association between APOE and hippocampal volume and amyloid deposition. Meta-analysis was performed using effect size signed differential mapping using coordinates extracted from clusters with statistically significant difference in cerebral metabolic rate for glucose between APOE epsilon 4+ and epsilon 4- groups. Results APOE epsilon 4 carrier status was associated with atrophic hippocampal volume (pooled SMD: -0.47; 95% CI -0.82 to -0.13; p=0.007) and increased cerebral amyloid positron emission tomography tracer (pooled SMD: 0.62, 95% CI 0.27 to 0.98, p=0.0006). APOE epsilon 4 was also associated with decreased cerebral metabolism, especially in right middle frontal gyrus. Conclusions APOE epsilon 4 was associated with atrophic hippocampal volume in MRI markers, increased cerebral amyloid deposition and cerebral hypometabolism. Theses associations may indicate the potential role of the APOE gene in the pathophysiology of Alzheimer's disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available